We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

- Relapsing Remitting Multiple Sclerosis
- Terminated

Study Title: Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Teva Identifier: TNC GA MS 2004_01

ClinicalTrials.gov Identifier: NCT00203047

Study Status: Terminated

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 55 Years

Trial Duration: 01/01/2005 - 05/01/2009

Phase: Phase 4

Study Type

Interventional